Have a personal or library account? Click to login
Cannabigerol and cannabichromene in Cannabis sativa L. Cover

Cannabigerol and cannabichromene in Cannabis sativa L.

Acta Pharmaceutica
Volume 71 (2021): Issue 3 (September 2021)
By: Marjeta Zagožen,  Andreja Čerenak and  Samo Kreft  
Open Access
|Dec 2020

Authors

Marjeta Zagožen

marjeta.zagozen@ihps.si

Department for Plants, Soil, and Environment, Slovenian Institute of Hop Research and Brewing, Slovenia

Andreja Čerenak

Department for Plants, Soil, and Environment, Slovenian Institute of Hop Research and Brewing, Slovenia

Samo Kreft

The Chair of Pharmaceutical Biology University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/acph-2021-0021 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 355 - 364
Accepted on: Jul 23, 2020
|
Published on: Dec 31, 2020
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
cannabinoids,
chemotype,
health effects,
hemp,
receptors
Related subjects:
Pharmacy,
Pharmacy, other

© 2020 Marjeta Zagožen, Andreja Čerenak, Samo Kreft, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 71 (2021): Issue 3 (September 2021)Next article